Canbisol
Canbisol is a synthetic cannabinoid that was developed in the 1970s. It is a non-psychoactive compound, meaning it does not produce the "high" associated with cannabis. Canbisol has been studied for its potential therapeutic uses, particularly in the treatment of glaucoma and epilepsy.
History[edit]
Canbisol was first synthesized in the 1970s by a team of researchers at the University of Mississippi. The team was led by Dr. Raphael Mechoulam, a renowned chemist known for his work on cannabinoids. The goal of the research was to create a synthetic cannabinoid that could be used for medical purposes without the psychoactive effects of cannabis.
Structure and Properties[edit]
Canbisol is a synthetic cannabinoid, meaning it is not naturally occurring but is chemically similar to the cannabinoids found in the cannabis plant. It is a non-psychoactive compound, which means it does not produce the "high" associated with cannabis use. This makes it a potential candidate for therapeutic uses where the psychoactive effects of cannabis are not desired.
Medical Uses[edit]
Canbisol has been studied for its potential therapeutic uses. It has been found to be particularly effective in the treatment of glaucoma, a condition that causes increased pressure in the eye and can lead to vision loss. Canbisol works by reducing intraocular pressure, helping to prevent damage to the optic nerve.
In addition to its use in treating glaucoma, Canbisol has also been studied for its potential use in treating epilepsy. Some studies have found that it can reduce the frequency and severity of seizures in some patients.
Legal Status[edit]
The legal status of Canbisol varies by country. In some countries, it is classified as a controlled substance, while in others it is legal for medical use. It is important to check the laws in your specific location before using Canbisol.
See Also[edit]
Canbisol[edit]
-
Structure of Canbisol -
3D Ball-and-Stick Model of Canbisol
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa
Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
